Oxidized LDL stimulates the expression of TGF-β and fibronectin in human glomerular epithelial cells

Kidney International

Volumn 51, Issue 1, 1997, Pages 147-154

  Ding, Guohua ^b   Van Goor, Harry ^b   Ricardo, Sharon D ^b   Orlowski, Janis M ^b   Diamond, Jonathan R ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; LOW DENSITY LIPOPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GLOMERULOSCLEROSIS; GLOMERULUS EPITHELIUM; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KIDNEY CELL CULTURE; OXIDATION; PRIORITY JOURNAL;

EID: 0031048601     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.18     Document Type: Article

References (54)

1. KEANE WF, MULCAHY WS, KASISKE BL, KIM Y, O'DONNELL MP: Hyperlipidemia and progressive renal disease. Kidney Int 39(Suppl 31):S41-S48, 1991
2. DIAMOND JR: Hyperlipidemia of nephrosis: Pathophysiologic role in progressive glomerular disease. Am J Med 87:5-25N-5-29N, 1989
3. JOVEN J, VILLABONA C, VILELLA E, MASANA L, ALBERTI R, VALLES M: Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N Engl J Med 323:579-584, 1990
4. GHERARDI E, ROTA E, CALANDRA S, GENOVA R, TAMBORINO A: Relationship among the concentration of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome. Eur J Clin Invest 7:563-570, 1977
5. MULS E, ROSSENEU M, DANEELS R, SCHURGERS M, BOELAERT J: Lipoprotein distribution and composition in the human nephrotic syndrome. Atherosclerosis 54:225-237, 1985
6. LEE HS, LEE JS, KOH HI, KO KW: Intraglomerular lipid depostion in routine biopsies. Clin Nephrol 36:67-75, 1991
7. MOORHEAD JF, CHAN MK, EL-NAHAS M, VARGHESE Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease. Lancet ii:1309-1311, 1982
8. GROND J, VAN GOOR H, ERKELENS DW, ELEMA JD: Glomerular sclerotic lesions in the rat. Virchows Arch 51:521-534, 1986
9. MAGIL AB, FROHLICH JJ, INNIS SM, STEINBRECHER UP: Oxidized low density lipoprotein in experimental focal glomerulosclerosis. Kidney Int 43:1243-1250, 1993
10. VAN GOOR H, VAN DEN HORST MLC, ATMOSOERODJO J, JOLES JA, VAN TOL A, GROND J: Renal apolipoproteins in nephrotic rats. Am J Pathol 142:1804-1912, 1993
11. DIAMOND JR, KARNOVSKY MJ: Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation. Kidney Int 32:671-677, 1987
12. KASISKE BL, O'DONNELL MP, GARVIS WJ, KEAN WF: Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure. Cin Res 62:367-374, 1988
13. HARRIS KPG, PURKERSON ML, YATES J, KLAHR S: Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome. Am J Kid Dis 15:16-26, 1990
14. DIAMOND JR, HANCHAK NA, MCCARTER MD, KARNOVSKY MJ: Choleastyramine resin ameliorates chronic aminonucleoside nephrosis. Am J Clin Nutr 51:606-611, 1990
15. VAN GOOR H, FIDLER V, WEENING JJ, GROND J: Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation: Evidence for involvement of macrophages and lipids. Lab Invest 64:754-765, 1991
16. AL-SHEBEB T, FROHLICH J, MAGIL AB: Glomerular disease in hypercholesterolemic guinea pigs: A pathogenic study. Kidney Int 33:498-507, 1988
17. TAKAMURA T, YOSHIOKA K, AYA N, MURAKAMI K, MATUMOTO A, ITAKURA H, KODAMA T, SUZUKI H, MAKI S: Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney Int 43:918-927, 1993
18. SATO H, SUZUKI S, KOBAYASHI H, OGINO S, INOMATA A, ARAKAWA M: Immunohistological localization of apolipoproteins in the glomeruli in renal disease: Specifically apo B and apo E. Clin Nephrol 36:127-133, 1991
19. GRÖNE H-J, WALLI AK, GRÖNE E, KRÄMER A, CLEMENS MR, SEIDEL D: Receptor mediated uptake of apo B and apo E rich lipoproteins by human glomerular epithelial cells. Kidney Int 37:1449-1459, 1990
20. RAYNER HC, HORSBURGH T, BROWN SL, LAVENDER FL, WINDER AF, WALLS J: Receptor-mediated endocytosis of low-density lipoprotein by cultured human glomerular cells. Nephron 55:292-299, 1990
21. KRÄMER A, NAUCK M, PAVENSTADT, SCHWEDLER S, WIELAND H, SCHOLLMEYER P, WANNER C: Receptor-mediated uptake of IDL and LDL from nephrotic patients by glomerular epithelial cells. Kidney Int 44:1341-1351, 1993
22. BROWN MS, GOLDSTEIN JL: Scavenging for receptors. Nature 343: 508-509, 1990
23. WASSERMAN J, SANTIAGO A, RIFICI V, HOLTHOFFER H, SCHARSCHMIDT L, EPSTEIN M, SCHLONDORFF D: Interactions of low density lipoprotein with rat meangial cells. Kidney Int 35:1168-1174, 1989
24. WHEELER DC, FERNANDO RL, GILLETT MPT, ZARUBA J, PERSAUD J, KINSTONE D, VARGHESE Z, MOORHEAD JF: Characterization of the binding of low-density lipoproteins to cultured rat mesangial cells. Nephrol Dial Transplant 6:701-708, 1991
25. CORITSIDIS G, RIFICI V, GUPTA S, RIE J, SHAN Z, NEUGARTEN J, SCHLONDORFF D: Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro. Kidney Int 39:858-866, 1991
26. GRÖNE EF, ABBOUD HE, HÖHNE M, WALLJ AK, GRÖNE H-J, STÜKEN D, ROBENEK H, WIELAND E, SEIDEL D: Action of lipoproteins in cultured human mesangial cells: Modulation by mitogenic vasoconstrictions. Am J Physiol 263:F686-F696, 1992
27. WHEELER DC, CHANA RS, TOPLEY N, PETERSEN MM, DAVIES M, WILLIAMS JD: Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury. Kidney Int 45:1628-1639, 1994
28. STUDER RK, CARVEN PA, DERUBERTIS FR: Low-density lipoprotein stimulation of mesangial cell fibronectin synthesis: Role of protein kinase C and transforming growth factor-B. J Lab Clin Med 125:86-95, 1995
29. ROVIN BH, TAN LC: LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int 43:218-225, 1993
30. KIM BA, KANG SA, CHO YJ, PARK S-K, CHEONG HI, LEE JD, HOND CD, PARK JS: Effects of low density lipoprotein on type IV collagen production by cultured rat messagial cell. Nephron 67:327-333, 1994
31. BORDER WA, NOBLE NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 10:1286-1292, 1994
32. MACKAY K, STRIKER LJ, STAUFFER JW, DOI T, AGODOA LY, STRIKER G: Transforming growth factor-β. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 83:1160-1167, 1989
33. BORDER WA, OKUDA S, LANGUINO LR, RUOSLAHTI E: Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int 37:689-695, 1990
34. NAKAMURA T, MILLER D, RUOSLAHTI E, BORDER WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β1. Kidney Int 41:1213-1221, 1992
35. DING G, PESEK-DIAMOND I, DIAMOND JR: Cholesterol, macrophage, and gene expression of TGF-β1 and fibronectin during nephrosis. Am J Physiol 264:F577-F584, 1993
36. KIRSCHENBAUM MA, PAI R, ROH DD, KAMANNA VS: Role of atherogenic lipoproteins in cytokine-mediated renovascular injury. Miner Electrol Metab 22:47-50, 1996
37. STRIKER GE, STRIKER LJ: Biology of disease: Glomerular cell culture. Lab Invest 53:121-135, 1985
38. ORLOWSKI JM: Puromycin aminonucleoside (PAN) in glomerular epithelial cell (GEC) culture: A model for human glomerular disease. (abstract) J Am Soc Nephrol 4:905, 1993
39. HARPER PA, ROBINSON JM, HOOVER RL, WRIGHT TC, KARNOVSKY MJ: Improved methods for culturing rat glomerular cells. Kidney Int 26:875-880, 1984
40. HOLTHOFER H, SAINO K, MIETTINEN P: Rat glomerular cells do not express podocytic markers when cultured in vitro. Lab Invest 65:548-557, 1991
41. DELARUE F, VIRONE A, HAGEGE J, LACAVE R, PERALDO M-N, ADIDA C, RONDEAU E, FEUNEUN J, SRAER J-D: Stable cell line of T-SV40 immortalized human glomerular visceral epithelial cells. Kidney Int 40:906-912, 1991
42. GOLDSTEIN JL, BASU SK, BROWN MS: Receptor-mediated endocytosis of low density lipoprotein in cultured cells. Meth Enzymol 98:241-259, 1983
43. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
44. DING G, VAN GOOR H, FRYE J, DIAMOND JR: Transforming growth factor-β expression in macrophages during hypercholesterolemic states. Am J Physiol 267:F937-F943, 1994
45. KASINATH BS: Resident glomerular cells in glomerular injury: Glomerular epithelial cells. Semin Nephrol 11:294-303, 1991
46. SCHWARTZ MM, LEWIS EJ: Focal segmental glomerular sclerosis: The cellular lesion. Kidney Int 28:968-974, 1985
47. FLOEGE J, JOHNSON RJ, ALPERS CE, FATEMI-NAINIE S, RICHARDSON CA, GORDON K, COUSER WG: Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B chain. Am J Pathol 142:637-650, 1993
48. ZWIJSEN RML, JAPENGA SC, HEIJEN AMP, VAN DEN BOS RC, KOEMAN JH: Induction of platelet-derived growth factor chain A gene expression in human smooth muscle cells by oxidized low density lipoproteins. Biochem Biophys Res Comm 186:1410-1416, 1992
49. GALLE J, STUNZ P, SCHOLLMEYER P, WANNER C: Oxidized LDL and lipoprotein (a) stimulate renin release of juxtaglomerular cells. Kidney Int 47:45-52, 1995
50. HERSCHMAN HR: primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem 60:281-319, 1991
51. NEWTON R, ADCOCK IM, BARNES PJ: superinduction of NF-κB by actinomycin D and cycloheximide in epithelial cells. Biochem Biophys Res Comm 218:518-523, 1996
52. ISAKA Y, FUJIWARA Y, UEDA N, KANEDA Y, KAMADA T, IMAI E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92:2597-2601, 1993
53. YAMAMOTO T, NOBLE NA, COHEN AH, NAST CC, HISHIDA A, GOLD LI, BORDER WA: Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int 49:461-469, 1996
54. KANAME S, UCHIDA S, OGATA E, KUROKAWA K: Autocrine secretion of transforming growth factor-β in cultured rat mesangial cells. Kidney Int 42:1319-1327, 1992